United States Cardiovascular Prosthetic Devices Market Outlook to 2020 - KPTV - FOX 12

United States Cardiovascular Prosthetic Devices Market Outlook to 2020

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Reportlinker

NEW YORK, May 26, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

United States Cardiovascular Prosthetic Devices Market Outlook to 2020

http://www.reportlinker.com/p02127403/United-States-Cardiovascular-Prosthetic-Devices-Market-Outlook-to-2020.html

United States Cardiovascular Prosthetic Devices Market Outlook to 2020

Summary

GlobalData's new report, "United States Cardiovascular Prosthetic Devices Market Outlook to 2020", provides key market data on the United States Cardiovascular Prosthetic Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Cardiac Valve Repairs and Septal Occluders.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Cardiovascular Prosthetic Devices market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Cardiovascular Prosthetic Devices categories - Cardiac Valve Repairs and Septal Occluders.
- Annualized market revenue (USD million), volume (units) and average selling price ($) data for the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
- 2012 company shares and distribution shares data for the market category.
- Global corporate-level profiles of key companies operating within the United States Cardiovascular Prosthetic Devices market.
- Key players covered include Medtronic, Inc., Edwards Lifesciences Corporation, St. Jude Medical, Inc. and Sorin Group.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

1 Table of Contents

2 Introduction 5
2.1 What Is This Report About? 5
2.2 Cardiovascular Prosthetic Devices Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Cardiovascular Prosthetic Devices Market, United States 7
3.1 Cardiovascular Prosthetic Devices Market, United States, Revenue ($m), 2005-2012 7
3.2 Cardiovascular Prosthetic Devices Market, United States, Revenue ($m), 2012-2020 9
3.2.1 Septal Occluders Market, United States, Revenue ($m), by Segment, 2005-2012 11
3.2.2 Septal Occluders Market, United States, Revenue ($m), by Segment, 2012-2020 13
3.3 Cardiovascular Prosthetic Devices Market, United States, Volume (Units), 2005-2012 15
3.4 Cardiovascular Prosthetic Devices Market, United States, Volume (Units), 2012-2020 17
3.4.1 Septal Occluders Market, United States, Volume (Units), by Segment, 2005-2012 19
3.4.2 Septal Occluders Market, United States, Volume (Units), by Segment, 2012-2020 21
3.5 Cardiovascular Prosthetic Devices Market, United States, Average Price ($), 2005-2020 23
3.6 Cardiovascular Prosthetic Devices Market, United States, Distribution Share by Revenue ($m), 2011-2012 25
3.7 Cardiovascular Prosthetic Devices Market, United States, Company Share by Revenue ($m), 2011-2012 26
4 Overview of Key Companies in United States, Cardiovascular Prosthetic Devices Market 28
4.1 St. Jude Medical, Inc. 28
4.1.1 Company Overview 28
4.2 Edwards Lifesciences Corporation 28
4.2.1 Company Overview 28
4.3 Medtronic, Inc. 29
4.3.1 Company Overview 29
4.4 W. L. Gore & Associates, Inc. 29
4.4.1 Company Overview 29
4.5 Sorin S.p.A. 29
4.5.1 Company Overview 29
5 Cardiovascular Prosthetic Devices Market Pipeline Products 30
6 Financial Deals Landscape 31
6.1 Venture Financing 31
6.1.1 JenaValve Raises US$10 Million In Extended Series C Financing 31
6.1.2 SynCardia Systems Raises US$14 Million In Venture Financing 34
6.1.3 JenaValve Technology Raises US$62.5 Million In Series C Financing Round 35
7 Recent Developments 38
7.1 Corporate Communications 38
7.1.1 May 24, 2013: Cook Medical Gets Class I Recall From FDA For Zilver PTX Drug Eluting Peripheral Stent 38
7.2 Financial Announcements 38
7.2.1 Mar 13, 2014: Skyline Medical to Penetrate Important Northeast Region Through Exclusive Distribution Agreement with O.R. Specialties 38
7.2.2 Jun 10, 2013: Exact Sciences Submits Final Module And Completes Cologuard Premarket Approval Application To FDA 39
8 Appendix 41
8.1 Research Methodology 42
8.1.1 Coverage 42
8.1.2 Secondary Research 42
8.1.3 Primary Research 43
8.1.4 Market Modeling and Forecasting 44
8.1.5 Company Share Analysis 47
8.1.6 Distribution Share Analysis 48
8.2 Expert Panel 48
8.3 GlobalData Consulting 49
8.4 Contact Us 49
8.5 Disclaimer 49

1.1 List of Tables

Table 1: Cardiovascular Prosthetic Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 8
Table 2: Cardiovascular Prosthetic Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 10
Table 3: Septal Occluders Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 12
Table 4: Septal Occluders Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 14
Table 5: Cardiovascular Prosthetic Devices Market, United States, Volume (Units), Historic, 2005-2012 16
Table 6: Cardiovascular Prosthetic Devices Market, United States, Volume (Units), Forecast, 2012-2020 18
Table 7: Septal Occluders Market, United States, Volume (Units), Historic, 2005-2012 20
Table 8: Septal Occluders Market, United States, Volume (Units), Forecast, 2012-2020 22
Table 9: Cardiovascular Prosthetic Devices Market, United States, Average Price ($), Historic, 2005-2012 23
Table 10: Cardiovascular Prosthetic Devices Market, United States, Average Price ($), Forecast, 2012-2020 24
Table 11: Cardiovascular Prosthetic Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2011-2012 25
Table 12: Cardiovascular Prosthetic Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2011-2012 27
Table 13: Cardiovascular Prosthetic Devices Market Pipeline Products 30
Table 14: JenaValve Raises US$10 Million In Extended Series C Financing 31
Table 15: SynCardia Systems Raises US$14 Million In Venture Financing 34
Table 16: JenaValve Technology Raises US$62.5 Million In Series C Financing Round 35
Table 17: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country 44

1.2 List of Figures

Figure 1: Cardiovascular Prosthetic Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 7
Figure 2: Cardiovascular Prosthetic Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 9
Figure 3: Septal Occluders Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 11
Figure 4: Septal Occluders Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 13
Figure 5: Cardiovascular Prosthetic Devices Market, United States, Volume (Units), Historic, 2005-2012 15
Figure 6: Cardiovascular Prosthetic Devices Market, United States, Volume (Units), Forecast, 2012-2020 17
Figure 7: Septal Occluders Market, United States, Volume (Units), Historic, 2005-2012 19
Figure 8: Septal Occluders Market, United States, Volume (Units), Forecast, 2012-2020 21
Figure 9: Cardiovascular Prosthetic Devices Market, United States, Company Share (%), 2012 26
Figure 10: GlobalData Epidemiology-Based Forecasting Model 46
Figure 11: GlobalData Capital Equipment-Based Forecasting Model 47
Figure 12: Primary Interviews by Participant Type (%) 48

To order this report: United States Cardiovascular Prosthetic Devices Market Outlook to 2020
http://www.reportlinker.com/p02127403/United-States-Cardiovascular-Prosthetic-Devices-Market-Outlook-to-2020.html

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
FOX 12
Powered by WorldNow CNN
All content © 2014, KPTV-KPDX Broadcasting Corporation, Portland, OR and WorldNow. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.